I'm the queen of "Post-Its". I have Post-Its on tables, counters, walls, doors. I don't know how I lived without them.
I guess, in the "old" days, I was the same with lists. Many lists. And way too much Scotch Tape.
Factoid: The man who invented Post-Its was an employee at 3M (also the maker of Scotch Tape) who went to his boss with a bright new idea. I don't know if he got a raise, but he gets no royalties. Just my undying admiration and thanks.
Anyway, short of taking stock in 3M, here are some other suggestions...
This letter has been created by the Epilepsy Foundation to make explicitly sure that no substitutions are made to your prescription without full consent by you and your doctor. You might want to make a copy of it for your files. Dear Pharmacist: Thank you for providing me with the valuable service of filling my needed prescriptions. The purpose of this letter is to let you know that I have epilepsy and it is vital that I receive the same medication from the same manufacturer monthly in order to maintain the expected level of seizure control and side effects. Please ensure that no changes are made to my medications, including a change in manufacturer, without prior consent from my physician and myself. Please note this request in my file. To assist you, I have listed below the name, manufacturer, and dosage of the medications I am currently taking. Thank you very much, Your Signature________________________________________ Today's Date______________________ Your Printed Name_____________________________________ Phone Number____________________ Physician's Name______________________________________ Phone Number____________________ Brand Name__________________________________________ Generic Name_________________________________________ Manufacturer _________________________________________ Dosage ______________________________________________ Epilepsy Foundation of America Not another moment lost to seizures
MORRISTOWN, N.J., Sept. 13, 2011 /PRNewswire/ Watson Laboratories, Inc. has confirmed today that it has launched Levetiracetam Extended-Release 500 mg and 750 mg tablets — the generic version of Keppra XRÂ® — following approval of the Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration (FDA).
Watson has begun shipping the product today. Keppra XRÂ® is indicated to treat partial onset seizures in people 16 years of age and older with epilepsy.
There's a very cool new book of poetry out by Maggie Mendus. It's called "Broken Consciousness" Reflections of an Epileptic.
I just finished reading it and as the reviews say: "Hauntingly accurate descriptions written from the patient perspective capture the true emotions evoked by epilesy. Conveying frustration, fear, strength, hope and courage, this is a must read for anyone touched by epilepsy, whether patient, family, friend or health care professional. After working with epilepsy patients for years, I see how these poems will launch our perspective and understanding into a new light. Brilliant and insightful. A must read!"
Steven H. Schechter, MD -- Clinical Associate Professor of Neurology, Wayne State University, Detroil, MI and William Beaumont Hospital, Royal Oak, MI